Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    SDC Agro Vet India Pvt Ltd

    SDC Agro Vet India Pvt Ltd is a manufacturer of speciality products of advanced feed supplements, natural plant extracts and probiotics technology for the commercial culture of

  • No Image
    Sequent Scientific Ltd

    Sequent Scientific Ltd is an integrated pharmaceuticals company with presence in human and animal Active Pharmaceutical Ingredients (APIs) and veterinary formulations. During FY

  • No Image
    Shanpar Industries Pvt Ltd

    ShanPar Industries Pvt. Ltd. offers Nutraceuticals, Mineral Fortifiers, Feed Additives & Specialty Chemicals. They specialize in continuous development and introduction of newer

  • No Image
    Shantha Biotechnics Pvt Ltd

    Shantha Biotechnics Pvt Ltd, a wholly owned subsidiary of Sanofi group and is located in Hyderabad, Telangana. The company was founded by Dr. Varaprasad Reddy in 1993 and is th

  • No Image
    Sharon Bio Medicine Ltd

    Sharon Bio-Medicine Limited is a Indian Pharmaceutical, Company listed at Bombay Stock Exchange. Over the years it has evolved from being a manufacturer of Intermediates & Activ